This is completely consistent with our previous findings of increased antibody reactivities towards HERV-H/RGH-2 Env and Gag peptides associated with high MS disease activity compared with control groups such as patients with autoimmune diseases, patients with other neurological diseases, or healthy relatives of MS patients [17,18]. The gene discussed is ERVW-1; the disease is myeloid sarcoma.